The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
IL-6 Controls Leukemic Multipotent Progenitor Cell Fate and Contributes to Chronic Myelogenous Leukemia Development
Open accessAbstract
Using a mouse model recapitulating the main features of human chronic myelogenous leukemia (CML), we uncover the hierarchy of leukemic stem and progenitor cells contributing to disease pathogenesis. We refine the characterization of CML leukemic stem cells (LSCs) to the most immature long-term hematopoietic stem cells (LT-HSCs) and identify some important molecular deregulations underlying their aberrant behavior. We find that CML multipotent progenitors (MPPs) exhibit an aberrant B-lymphoid potential but are redirected toward the myeloid lineage by the action of the proinflammatory cytokine IL-6. We show that BCR/ABL activity controls Il-6 expression thereby establishing a paracrine feedback loop that sustains CML development. These results describe how proinflammatory tumor environment affects leukemic progenitor cell fate and contributes to CML pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In particular, the SASP-associated cytokines TNF, IFN, and IL-6 all play significant roles in the pathogenesis of myeloproliferative neoplasms (MPNs), 52 MDSs, 53 and acute myeloid leukemia (AML).54”
From Inflammatory bone marrow microenvironment (2019) · cites this paper as [52]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Impaired immune and acute-phase responses in interleukin-6-deficient mice
Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H., & Köhler, G. (1994) · Nature · doi:10.1038/368339a0 · Cited by 1,768 · cited 2×
“IL-6 Contributes to CML Development To confirm the function of IL-6 in CML pathogenesis, we evaluated disease progression in the absence of IL-6 signaling by crossing BA mice with Il-6 / mice (Kopf et al., 1994).”
MethodIliopoulos, D., Hirsch, H. A., & Struhl, K. (2009) · Cell · doi:10.1016/j.cell.2009.10.014 · Cited by 1,374
BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros
Mullighan, C. G., Miller, C. B., Radtke, I., Phillips, L. A., Dalton, J., Ma, J., White, D., Hughes, T. P., Le Beau, M. M., Pui, C.-H., et al. (2008) · Nature · doi:10.1038/nature06866 · Cited by 1,072
Lin28 promotes transformation and is associated with advanced human malignancies
Viswanathan, S. R., Powers, J. T., Einhorn, W. S., Hoshida, Y., Ng, T., Toffanin, S., O’Sullivan, M. J., Lü, J., Phillips, L. A., Lockhart, V. L., et al. (2009) · Nature Genetics · doi:10.1038/ng.392 · Cited by 835
Self-citationCorbin, A. S., Agarwal, A., Loriaux, M., Cortes, J., Deininger, M. W., & Druker, B. J. (2011) · Journal of Clinical Investigation · doi:10.1172/jci35721 · Cited by 765
Huntly, B. J. P., Shigematsu, H., Deguchi, K., Lee, B. H., Mizuno, S., Duclos, N., Rowan, R., Amaral, S., Curley, D., Williams, I. R., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.10.015 · Cited by 697
Gene expression changes associated with progression and response in chronic myeloid leukemia
Radich, J. P., Dai, H., Mao, M., Oehler, V., Schelter, J., Druker, B., Sawyers, C., Shah, N., Stock, W., Willman, C. L., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510423103 · Cited by 583
Self-citationHolyoake, T. L., Jiang, X., Eaves, C. J., & Eaves, A. C. (1999) · Blood · doi:10.1182/blood.v94.6.2056 · Cited by 511
Cell cycle regulation in hematopoietic stem cells
Pietras, E. M., Warr, M. R., & Passegué, E. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201102131 · Cited by 447
Self-citationChronic myeloid leukemia: mechanisms of blastic transformation
Perrotti, D., Jamieson, C. H. M., Goldman, J. M., & Skórski, T. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41246 · Cited by 402
A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia
Klinakis, A., Lobry, C., Abdel-Wahab, O. I., Oh, P., Haeno, H., Buonamici, S., de Walle, I. V., Cathelin, S., Trimarchi, T., Araldi, E., et al. (2011) · Nature · doi:10.1038/nature09999 · Cited by 400
Interleukin‐6 and its receptor in cancer: Implications for Translational Therapeutics
Hong, D. S., Angelo, L. S., & Kurzrock, R. (2007) · Cancer · doi:10.1002/cncr.22999 · Cited by 370
Modeling the Initiation and Progression of Human Acute Leukemia in Mice
Barabé, F., Kennedy, J. A., Hope, K. J., & Dick, J. E. (2007) · Science · doi:10.1126/science.1139851 · Cited by 357
Hu, Y., Swerdlow, S., Duffy, T. M., Weinmann, R. S., Lee, F. Y., & Li, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606509103 · Cited by 274
Zhang, B., Strauss, A. C., Chu, S., Li, M., Ho, Y., Shiang, K.-D., Snyder, D., Huettner, C. S., Shultz, L. D., Holyoake, T. L., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.011 · Cited by 256
Jiang, X., Lopez, A. F., Holyoake, T. L., Eaves, A. C., & Eaves, C. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12804 · Cited by 227
Koschmieder, S., Göttgens, B., Zhang, P., Iwasaki-Arai, J., Akashi, K., Kutok, J. L., Dayaram, T., Geary, K., Green, A. R., Tenen, D. G., et al. (2004) · Blood · doi:10.1182/blood-2003-12-4369 · Cited by 223
Intermediate-Term Hematopoietic Stem Cells with Extended but Time-Limited Reconstitution Potential
Benveniste, P. M., Frelin, C., Janmohamed, S., Barbara, M., Herrington, R., Hyam, D., & Iscove, N. N. (2010) · Cell stem cell · doi:10.1016/j.stem.2009.11.014 · Cited by 219
BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR–ABL1 kinase inhibition
Duy, C., Hurtz, C., Shojaee, S., Cerchietti, L. C. A., Geng, H., Swaminathan, S., Klemm, L., Kweon, S.-M., Nahar, R. R., Braig, M., et al. (2011) · Nature · doi:10.1038/nature09883 · Cited by 204
Getting to the stem of chronic myeloid leukaemia
Savona, M. R., & Talpaz, M. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2368 · Cited by 193
Santaguida, M. A., Schepers, K., King, B., Sabnis, A. J., Forsberg, E. C., Attema, J. L., Braun, B. S., & Passegue, E. A. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.02.016 · Cited by 159
Schmidt, T., Masouleh, B. K., Loges, S., Cauwenberghs, S., Fraisl, P., Maes, C., Jonckx, B., Keersmaecker, K. D., Kleppe, M., Tjwa, M., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.05.007 · Cited by 139
Maeda, K., Malykhin, A., Weber, B., Sun, X.-H., Farris, A. D., & Coggeshall, K. M. (2009) · Blood · doi:10.1182/blood-2008-12-192559 · Cited by 119
Barnes, D. J., & Melo, J. V. (2006) · Cell Cycle · doi:10.4161/cc.5.24.3573 · Cited by 117
Warr, M. R., Pietras, E. M., & Passegué, E. (2011) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.145 · Cited by 112
Self-citationIL-6 blocks a discrete early step in lymphopoiesis
Maeda, K., Baba, Y., Nagai, Y., Miyazaki, K., Malykhin, A., Nakamura, K., Kincade, P. W., Sakaguchi, N., & Coggeshall, K. M. (2005) · Blood · doi:10.1182/blood-2005-02-0456 · Cited by 100
BCR-ABL enhances differentiation of long-term repopulating hematopoietic stem cells
Schemionek, M., Elling, C., Steidl, U. G., Bäumer, N., Hamilton, A., Spieker, T., Göthert, J. R., Stehling, M., Wagers, A. J., Huettner, C. S., et al. (2010) · Blood · doi:10.1182/blood-2009-04-215376 · Cited by 96
Porosnicu, M., Nimmanapalli, R., Nguyen, D. N., Worthington, E., Perkins, C. L., & Bhalla, K. N. (2001) · Leukemia · doi:10.1038/sj.leu.2402104 · Cited by 94
Li, S., Gillessen, S., Tomasson, M. H., Dranoff, G., Gilliland, D. G., & Etten, R. A. V. (2001) · Blood · doi:10.1182/blood.v97.5.1442 · Cited by 74
BCL-6 negatively regulates macrophage proliferation by suppressing autocrine IL-6 production
Yu, R. Y.-L., Wang, X., Pixley, F. J., Yu, J. J., Dent, A. L., Broxmeyer, H. E., Stanley, E. R., & Ye, B. H. (2004) · Blood · doi:10.1182/blood-2004-08-3171 · Cited by 74
Marrow fibrosis and its relevance during imatinib treatment of chronic myeloid leukemia
Buesche, G., Ganser, A., Schlegelberger, B., Neuhoff, N. V., Gadzicki, D., Hecker, H., Bock, O., Frye, B., & Kreipe, H. H. (2007) · Leukemia · doi:10.1038/sj.leu.2404917 · Cited by 63
Leukemic Stem Cells: Where do They Come From?
Passegue, E. A., & Weisman, I. L. (2005) · Stem Cell Reviews and Reports · doi:10.1385/scr:1:3:181 · Cited by 51
Anand, M., Chodda, S. K., Parikh, P. M., & Nadkarni, J. S. (1998) · Hematological Oncology · doi:10.1002/(sici)1099-1069(199812)16:4 · Cited by 48
Flagged first, then by citations
Cited by
Sorted by citations
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
Yu, H., Lee, H., Herrmann, A., Buettner, R., & Jove, R. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3818 · Cited by 2,137
Pietras, E. M., Reynaud, D., Kang, Y.-A., Carlin, D., Calero-Nieto, F. J., Leavitt, A. D., Stuart, J. M., Göttgens, B., & Passegué, E. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.05.003 · Cited by 723
Self-citationSchepers, K., Pietras, E. M., Reynaud, D., Flach, J., Binnewies, M., Garg, T., Wagers, A. J., Hsiao, E. C., & Passegué, E. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.06.009 · Cited by 614
Self-citationBone marrow niches in haematological malignancies
Méndez‐Ferrer, S., Bonnet, D. A., Steensma, D. P., Hasserjian, R. P., Ghobrial, I. M., Gribben, J. G., Andreeff, M., & Krause, D. S. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0245-2 · Cited by 515
Inflammation: a key regulator of hematopoietic stem cell fate in health and disease
Pietras, E. M. (2017) · Blood · doi:10.1182/blood-2017-06-780882 · Cited by 417
Self-citation
Metadata
- Authors
- Reynaud, D., Pietras, E., Barry-Holson, K., Mir, A., Binnewies, M., Jeanne, M., Sala-Torra, O., Radich, J. P., & Passegué, E.
- Affiliations
- University of California, San Francisco (US)
- Standard BioTools (United States) (US)
- Fred Hutch Cancer Center (US)
- Corresponding author
- Reynaud, Damien
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2011-11
- Volume
- 20
- Issue
- 5
- Pages
- 661-673
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC3220886
- OpenAlex
- W1974815398
- Cited by
- 335
- References
- 34
- Citations by year
- 2026: 10 · 2025: 22 · 2024: 17 · 2023: 26 · 2022: 26 · 2021: 33 · 2020: 27 · 2019: 23 · 2018: 19 · 2017: 25 · 2016: 20 · 2015: 28 · 2014: 24 · 2013: 19 · 2012: 16
- FWCI
- 12.92
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- University of California, San Francisco
- National Heart, Lung, and Blood Institute (HL092471, R01HL092471)
- Topics
- Health Sciences › Medicine › Hematology › Chronic Myeloid Leukemia Treatments
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Keywords
- interleukin-6, chronic myeloid leukemia, multipotent progenitors, leukemia stem cells, long-term hematopoietic stem cells, BCR-ABL, myeloid differentiation, paracrine signaling, cell fate specification
- MeSH terms
- Animals, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Interleukin-6, Fusion Proteins, bcr-abl, Feedback, Physiological, Multipotent Stem Cells, Mice, Precursor Cells, B-Lymphoid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
